Kang et al. have previously shown that ceramide synthesized through the de novo pathway upon hypoxia in SH-SY5Y neuroblastoma cells, and that ceramide synthase inhibition using fumonisin B1 reduced ceramide levels in hypoxic environments [17]. This evidence concerns the gene TLCD3B and neuroblastoma.